Somatic Mutations in Clonal Hematopoiesis Contribute to the Pathogenesis of Autism Spectrum Disorder
This study identifies postzygotic clonal hematopoiesis (CHIPI) as a distinct and significant genetic risk factor for autism spectrum disorder, revealing that CHIPI-related somatic mutations operate independently of germline pathways while mediating systemic immune, metabolic, and mitochondrial dysregulation exacerbated by endocrine-disrupting chemicals.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Autism spectrum disorder is a complex condition affecting how people communicate and interact with the world. For decades, scientists have looked for the cause of this condition primarily within the DNA we inherit from our parents. This inherited genetic code acts as a blueprint, present in every single cell of the body from the moment of conception. However, life is not static. As the body grows and cells divide, tiny errors can occur in the genetic instructions of individual cells. These are called somatic mutations. Unlike inherited changes, somatic mutations happen after birth and exist only in a specific group of cells, creating a kind of genetic mosaic within a single person. While these mutations are well known for causing cancer in older adults, their role in childhood developmental disorders has remained largely a mystery.
A team of researchers from Peking University and Ansheng Hospital has now turned their attention to a specific type of somatic mutation that occurs in blood cells. They focused on a phenomenon where a single cell acquires a mutation that gives it a survival advantage, allowing it to multiply and form a large clone of identical cells. In older adults, this is often linked to aging, but in young children, it can be triggered by environmental stressors. The researchers asked a simple but profound question: could these expanding clones of mutated blood cells be contributing to the development of autism? By examining the blood of children with autism and comparing it to typically developing children, they discovered a hidden layer of genetic risk that operates independently of the inherited genes previously studied.
The study began with a close look at the blood samples of 43 children diagnosed with autism and 26 children without the condition. The team used a powerful sequencing technique to read the genetic code of the blood cells, searching for those specific somatic mutations that had taken hold in a significant portion of the cells. They found that children with autism were far more likely to carry these mutations in a specific set of genes. In total, they identified 286 gene locations where these mutations were significantly more common in the autism group. What made this finding particularly striking was that these mutated genes were almost entirely different from the genes known to be inherited causes of autism. The overlap between the two groups was less than 1.6 percent. This suggests that the blood cell mutations represent a completely separate, distinct pathway to the condition, one that has been overlooked because it does not come from the parents.
To understand what these mutations were actually doing inside the body, the researchers looked beyond the DNA and examined the chemical environment of the children. They measured markers for inflammation, oxidative stress, and how the body's energy factories were working. The results painted a clear picture of systemic trouble. Children carrying these specific blood cell mutations showed signs of a body under constant attack. Their immune systems were in a state of high alert, producing elevated levels of inflammatory signals. Their cells showed signs of oxidative stress, a condition where harmful molecules damage proteins and DNA, similar to rust forming on metal. Furthermore, the mutations were linked to problems in the gut, where inflammation markers were higher, and to disruptions in the tricarboxylic acid cycle, a core process the body uses to generate energy. Essentially, the presence of these mutated blood cells seemed to be driving a state of chronic, low-level inflammation and metabolic stress throughout the entire body.
The researchers then investigated how these mutations might have started in the first place. They suspected that environmental factors, specifically chemicals that interfere with the body's hormones, might be the trigger. They measured levels of various endocrine-disrupting chemicals in the urine of the children. The data revealed a strong connection: higher levels of these environmental chemicals were associated with a higher likelihood of carrying the specific blood cell mutations. The team used statistical modeling to show that these chemicals likely act as the spark, causing the initial genetic errors in the blood cells. Once these errors occurred, the mutated cells expanded, and their abnormal activity drove the inflammation and metabolic issues that the researchers observed. This creates a chain of events where an environmental exposure leads to a somatic mutation, which in turn leads to the physiological disturbances seen in autism.
The study also looked at how these mutations related to the severity of the children's symptoms. Using a standard clinical assessment tool, the researchers found that children with specific mutation sites tended to have higher scores for social communication difficulties and repetitive behaviors. This suggests that the burden of these mutations is not just a biological curiosity but is directly tied to the real-world experience of the disorder. The mutations in genes like KMT2C, which appeared in both the new somatic findings and older inherited lists, hint at a point where different genetic risks might converge to shape the condition. However, the vast majority of the new findings were unique to this somatic pathway, operating on its own terms.
This work does not claim to have solved the mystery of autism, nor does it suggest that every case is caused by blood cell mutations. The researchers acknowledge that their sample size was limited and that the exact molecular mechanisms need further testing in animal models. They also noted that without paired samples from the same child's healthy tissue, they relied on strict statistical filters to distinguish these mutations from inherited ones. Despite these limitations, the study offers a compelling new perspective. It proposes that for a significant number of children, autism may not be solely a story of inherited blueprints, but also a story of how the body's blood cells respond to environmental challenges. By identifying a link between environmental toxins, blood cell mutations, and systemic inflammation, the research opens a new door for understanding the condition, suggesting that the path to autism might sometimes begin in the blood, long before it manifests in the brain.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.